Village Farms swings to profit on produce sale; Canadian cannabis drives margin recovery

Village Farms International, Inc. (NASDAQ: VFF) - Quick take

Q2 2025 shows the company swinging to profit after a transformational disposal of its Produce operations and strong Canadian cannabis performance. The quarter includes a large one‑time gain from the produce divestiture, improved cannabis margins and a cash build - but structural tax, debt and valuation‑allowance issues remain.

Key facts & figures (as reported)
* Sales (Q2 2025): $59,899 thousand
* Gross profit (Q2 2025): $22,342 thousand
* SG&A (Q2 2025): $15,411 thousand (26% of sales)
* Income before taxes (Q2 2025): $12,448 thousand
* Provision for income taxes (Q2 2025): $2,503 thousand
* Income from continuing operations (Q2 2025): $9,945 thousand
* Income from discontinued operations (Q2 2025): $16,294 thousand (includes gain on sale)
* Net income attributable to shareholders (Q2 2025): $26,497 thousand; basic EPS $0.24
* Adjusted EBITDA from continuing operations (Q2 2025): $17,111 thousand; Adjusted EBITDA total: $13,260 thousand
* Cash & cash equivalents (balance sheet): $59,988 thousand; Restricted cash: $5,000 thousand; Cash, cash equivalents & restricted cash (cash flow ending): $64,988 thousand
* Total assets: $403,744 thousand; Total liabilities: $109,552 thousand; Shareholders' equity: $284,337 thousand
* Total debt (principal outstanding at 6/30/25): $39,103 thousand; Long‑term debt (net of current maturities): $31,206 thousand
* Gain on sale of Produce assets (initial): $19,985 thousand; consideration included $35,000k cash, $5,000k escrow and Vanguard units valued $3,530k
* Deferred tax asset valuation allowance: $44,084 thousand (6/30/25)

What's happening inside the company
* Strategic refocus: VFF completed privatization of large parts of its Produce business (May 30, 2025) and now holds a 37.9% interest in Vanguard - the disposed assets and related gain are presented as discontinued operations.
* Core growth engine: Canadian Cannabis (Pure Sunfarms + Rose) is driving improved margins and materially better Adjusted EBITDA (Canadian Cannabis Adj. EBITDA Q2: $11,860k). International medical exports ramped sharply.
* New markets & buildout: Netherlands operation (Leli) began sales in 2025 and is ramping; management approved further cannabis production conversion at Delta, BC after quarter end.
* Balance sheet actions: Replaced/refinanced prior Pure Sunfarms loans with a consolidated C$37.4M facility (term + revolving) and amended FCC Term Loan - improving covenant profile and lowering interest costs.

Positive aspects of the income statement
* Revenue growth and better mix: Q2 sales up 12% YoY to $59.9M, driven by Canadian cannabis and first‑year contribution from Leli.
* Margin expansion: Consolidated gross profit rose to $22.3M (Q2) - Canadian Cannabis gross margin improved to ~39% (Q2 Canadian Cannabis gross profit $17,468k on $44,518k sales).
* Strong cash generation: Operating cash from continuing operations YTD $22.3M and total cash (including discontinued) rose sharply (net increase $40,357k during the period).
* Adjusted EBITDA recovery: Adjusted EBITDA from continuing operations $17.1M (Q2) vs $2.9M a year earlier; demonstrates operating leverage in cannabis operations.

Negative aspects / risks visible in the income statement and notes
* One‑time accounting boost: Large portion of Q2 net income reflects the gain on sale of Produce (gain recorded $19,985k). Recurring operating profit is smaller - monitor normalized earnings.
* Tax and deferred asset concerns: Provision for income taxes rose (Q2 $2.5M) and the company maintains a substantial valuation allowance on deferred tax assets of $44,084k, signaling uncertainty over ability to realize tax assets.
* Debt and interest exposure: Total principal debt $39.1M (weighted average short‑term borrowing rate 6.9% at 6/30/25); ongoing debt service and maturities (notably FCC term loan maturity 2027) remain a financing watch item.
* U.S. cannabis volatility: Prior goodwill/intangible impairments in U.S. Cannabis (year‑ago charge $11.9M) highlight fragility in that segment - though no impairment in 6/30/25, U.S. regulatory and market headwinds persist.
* Excise taxes & cost structure: Excise duty is a heavy drag (branded excise $14.8M in Q2), which compresses net realization from branded sales in Canada.

Key monitor items for investors
* How much of future EPS and EBITDA are repeatable vs. tied to the Vanguard gain and vendor settlements.
* Execution on Delta conversion and capacity expansion - management expects incremental production (post‑quarter investment funded from cash).
* Covenant compliance and interest costs after the April 2025 refinancings; quarterly debt maturities schedule and liquidity under the Pure Sunfarms revolver.
* International export traction and pricing trends - International sales were a major contributor to margin improvement this quarter.
* Any changes to the deferred tax valuation allowance if profitability proves sustainable.

Bottom line: Village Farms (NASDAQ: VFF) used a strategic sale of produce assets to crystallize value and strengthen liquidity while its Canadian cannabis business delivered stronger margins and Adjusted EBITDA. The improvement is real but partially one‑time; investors should separate recurring operating performance from disposal gains, monitor debt/covenant execution, and watch whether the company can convert the post‑transaction cash and margin momentum into sustainable, tax‑effective earnings.